Elevated levels of biomarkers of systemic inflammation, immune function, and ventricular remodeling, such as C-reactive protein (CRP), tumor necrosis factor (TNF), and endothelin-1, also have been associated with morbidity and mortality among heart failure patients (Alonso-Martinez et al. 2002; Anand et al. 2005; Dunlay et al. 2008; Teerlink 2005). This evidence concerns the gene CRP and heart failure.